Gastroenterology Practice Questions

Q: Which of the following would be least likely to cause an ulcer in the distal esophagus?

Zenker's diverticulum. The correct answer is **Zenker’s diverticulum**. The key to this question lies in the **anatomical location**. Zenker’s diverticulum is a pulsion diverticulum occurring at the **Killian’s dehiscence** (between the thyropharyngeus and cricopharyngeus muscles). This is located in the **proximal (upper) esophagus** or hypopharynx [1]. Therefore, it is anatomically impossible for it to cause an ulcer in the **distal esophagus**. **Analysis of Options:** * **HSV (Herpes Simplex Virus):** Viral esophagitis typically affects the squamous epithelium of the mid-to-distal esophagus. HSV characteristically causes small, "punched-out" ulcers. * **Achalasia Cardia:** While primarily a motility disorder, stasis of food and saliva in the dilated distal esophagus can lead to "stasis esophagitis" and subsequent mucosal ulceration [1]. * **Severe Reflux Esophagitis (GERD):** This is the most common cause of distal esophageal ulcers [2]. Chronic exposure to gastric acid and pepsin leads to mucosal erosion, typically just above the gastroesophageal junction. **NEET-PG High-Yield Pearls:** 1. **Zenker’s Diverticulum:** Presents with halitosis, regurgitation of undigested food, and a neck mass that "gurgles." It is a *false* diverticulum (only mucosa and submucosa herniate) [1]. 2. **Drug-Induced Esophagitis:** Often occurs at the level of the **arch of the aorta** (mid-esophagus) due to anatomical narrowing. Common culprits: Tetracyclines, NSAIDs, and Bisphosphonates. 3. **Cytomegalovirus (CMV):** Unlike the "punched-out" ulcers of HSV, CMV typically causes **large, solitary, linear ulcers** in the distal esophagus, especially in immunocompromised patients.

Q: Which of the following is NOT a treatment for hepatic encephalopathy?

High protein diet. Explanation: Hepatic Encephalopathy (HE) is a reversible neuropsychiatric syndrome caused by liver failure and portosystemic shunting [1]. The primary pathophysiology involves the accumulation of neurotoxic substances, most notably ammonia ($NH_3$), which crosses the blood-brain barrier [1]. Why Option A is the correct answer: Ammonia is a byproduct of protein metabolism by intestinal bacteria [1]. Historically, protein restriction was practiced; however, modern guidelines emphasize that high protein intake (1.2–1.5 g/kg/day) is essential to prevent muscle wasting (sarcopenia), which actually worsens HE because muscle helps detoxify ammonia [2]. Therefore, a "high protein diet" is a nutritional requirement, but protein restriction (not high protein) was the traditional (though now largely obsolete) "treatment" logic. In the context of this question, a high protein diet does not treat an acute episode; rather, it is the management of the underlying nutritional state. Why the other options are incorrect: * Lactulose (Option B): The first-line treatment. It is a non-absorbable disaccharide that acidifies the colon, converting $NH_3$ to non-absorbable $NH_4^+$ (ammonia trapping) and acts as an osmotic laxative. * Oral Neomycin (Option C): An antibiotic that reduces ammonia-producing bacteria in the gut. (Rifaximin is now preferred due to lower toxicity). * Enema (Option D): Used to rapidly clear the bowel of nitrogenous waste and blood (a common precipitant), reducing ammonia absorption. NEET-PG High-Yield Pearls: * Drug of Choice: Lactulose (for acute and maintenance). * Best Add-on Therapy: Rifaximin (reduces recurrence). * Most common precipitant: Infections (SBP), GI bleed, dehydration, or constipation. * Flumazenil: May be used transiently if benzodiazepine overdose is suspected as a trigger.

Q: Adequacy of D-penicillamine treatment in Wilson's disease is monitored by measuring which of the following?

24-hour urinary copper. ### Explanation **Correct Option: A (24-hour urinary copper)** D-penicillamine is a chelating agent that works by increasing the urinary excretion of copper. To monitor the **adequacy and compliance** of treatment, 24-hour urinary copper excretion is the gold standard. * **Initial Phase:** During the start of therapy, urinary copper levels are very high (>1000 µg/day). * **Maintenance Phase:** The goal is to maintain urinary copper excretion between **200–500 µg/day**. Levels below this range suggest non-compliance or under-dosage, while levels significantly higher may indicate the need for dose adjustment. **Why other options are incorrect:** * **B. Serum Ceruloplasmin:** This is a diagnostic marker (usually <20 mg/dL in Wilson's), but it does not change significantly with treatment and is not used for monitoring adequacy. [2] * **C. Disappearance of Kayser-Fleischer (KF) rings:** While KF rings may regress or disappear with successful treatment, this is a slow, subjective clinical finding and not a precise biochemical measure for titrating drug dosage. * **D. Serum copper level:** Total serum copper is usually low in Wilson's disease. While "Free Serum Copper" (Non-ceruloplasmin bound copper) is used to monitor therapy (target <10 µg/dL), total serum copper in a fasting state is not the standard monitoring tool. [1] **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** D-Penicillamine is the first-line chelator, but **Trientine** is preferred if the patient is intolerant or has neurological worsening. * **Mechanism:** D-penicillamine inhibits pyridoxine; hence, **Vitamin B6 supplementation** is mandatory. * **Monitoring Toxicity:** D-penicillamine can cause nephrotic syndrome and bone marrow suppression; regular **urinalysis and CBC** are required. * **Triad of Wilson's:** Liver disease, Neurological symptoms (Basal ganglia involvement), and KF rings (Descemet's membrane). [1]

Q: What is the recommended screening method for hepatocellular carcinoma (HCC) in patients with chronic liver disease?

Serial Ultrasound (USG) and Alpha-fetoprotein (AFP). **Explanation:** The primary goal of screening for Hepatocellular Carcinoma (HCC) is early detection in high-risk individuals (primarily those with cirrhosis or chronic Hepatitis B/C) [1] to allow for curative interventions. **Why Option A is Correct:** The current standard of care, supported by AASLD and EASL guidelines, is the combination of **Abdominal Ultrasound (USG) and Serum Alpha-fetoprotein (AFP)** performed every **6 months**. * **USG** is the preferred imaging modality due to its non-invasive nature, cost-effectiveness, and high specificity [1]. * **AFP** is a tumor marker that increases the sensitivity of screening when used alongside USG, as USG alone may miss small lesions in a nodular cirrhotic liver [1]. **Why Other Options are Incorrect:** * **Options B & D (LFTs):** Liver Function Tests (ALT, AST, Bilirubin) reflect the degree of liver inflammation or synthetic dysfunction but are not diagnostic or predictive of malignancy. * **Option C (CT Scan):** While Triple-phase CT is the gold standard for *diagnosis* [1], it is not used for *screening* due to high costs, radiation exposure, and the risk of contrast-induced nephropathy [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Screening Interval:** 6 months (based on the doubling time of HCC). * **Diagnostic Gold Standard:** Contrast-enhanced CT or MRI showing **"Wash-in"** (arterial enhancement) and **"Wash-out"** (venous/delayed phase) is diagnostic of HCC in cirrhotic patients [1]; a biopsy is often unnecessary. * **AFP Cut-off:** While >20 ng/mL is often used for screening, values >400 ng/mL are highly suggestive of HCC. * **Target Population:** All cirrhotic patients (Child-Pugh A and B) and specific non-cirrhotic HBV carriers.

Q: Very high serum transaminases (ALT/AST > 1000 IU/L) are seen in the following conditions except?

Alcoholic liver disease. In clinical practice, serum transaminase levels (AST and ALT) exceeding **1000 IU/L** indicate acute, massive hepatocellular necrosis [1]. **1. Why Alcoholic Liver Disease (ALD) is the correct answer:** In ALD, transaminases are typically only mildly to moderately elevated (usually ** 2:1**. **2. Why the other options are incorrect:** * **Viral Hepatitis:** Acute infection with hepatotropic viruses (A, B, or E) commonly causes "flaming" hepatitis with transaminases often reaching 1000–3000+ IU/L [1]. * **Ischemic Liver Injury ("Shock Liver"):** Rapid, massive elevation of AST/ALT (often >5000 IU/L) occurs due to hypoperfusion. A hallmark is the rapid rise followed by a rapid fall (within 48–72 hours) once perfusion is restored. * **Toxin-induced Liver Injury:** Acetaminophen (Paracetamol) toxicity is the most common cause of extremely high transaminases, sometimes exceeding 10,000 IU/L [1]. **Clinical Pearls for NEET-PG:** * **Highest elevations (>5000 IU/L):** Usually seen in Ischemic hepatitis or Acetaminophen toxicity [1]. * **AST > ALT:** Seen in Alcoholic liver disease, Cirrhosis, and Ischemic hepatitis. * **ALT > AST:** Seen in most cases of Acute Viral Hepatitis and NAFLD. * **Biliary Obstruction:** Acute common bile duct stones can cause a transient "spike" in transaminases (>1000) before bilirubin rises, but they settle quickly.

Q: Hepatorenal syndrome is characterized by all of the following except?

Presence of a precipitating cause. **Explanation:** Hepatorenal Syndrome (HRS) is a functional renal failure that occurs in patients with advanced chronic liver disease or acute liver failure [1]. It is primarily caused by extreme splanchnic vasodilation leading to severe renal vasoconstriction. **Why Option D is the correct answer:** While HRS can be triggered by precipitating factors (such as spontaneous bacterial peritonitis, GI bleeding, or over-diuresis), a **precipitating cause is NOT a requirement** for the diagnosis. HRS can occur spontaneously due to the progressive nature of portal hypertension. According to the International Club of Ascites (ICA) criteria, the diagnosis is based on the exclusion of other causes of kidney injury, not the presence of a trigger [1]. **Analysis of Incorrect Options:** * **Option A (Serum Creatinine >1.5 mg/dL):** Historically, this was a hallmark diagnostic threshold. While the newer ICA-AKI criteria focus on a rise in creatinine from baseline (≥0.3 mg/dL or 50% increase), a creatinine level >1.5 mg/dL remains a classic clinical indicator of significant renal impairment in HRS [1]. * **Option B (Intrinsically normal kidney):** HRS is a **functional** disorder. The kidneys are structurally intact and would function normally if transplanted into a patient with a healthy liver. * **Option C (Low or absent proteinuria):** Since the pathology is pre-renal (vasoconstrictive) rather than glomerular, there is typically no significant proteinuria (<500 mg/day) or hematuria [1]. **Clinical Pearls for NEET-PG:** * **Type 1 HRS:** Rapidly progressive; doubling of creatinine in <2 weeks [1]. * **Type 2 HRS:** Slowly progressive; associated with refractory ascites [1]. * **Urine Sodium:** Typically **<10 mEq/L** (due to intense sodium retention) [1]. * **Treatment of Choice:** Vasoconstrictors (**Terlipressin** is preferred) + **Albumin** [1]. * **Definitive Treatment:** Liver Transplantation [1].

Question 1

Which of the following would be least likely to cause an ulcer in the distal esophagus?

Accepted Answer

Zenker's diverticulum

Answer

HSV

Answer

Achalasia cardia

Answer

Severe reflux esophagitis

Question 2

A 23-year-old man has noted a yellow color to his sclerae for the past 2 weeks. On physical examination, he has generalized jaundice. He has the physique of a bodybuilder. Laboratory studies show serum total bilirubin, 5.6 mg/dL; ALT, 117 U/L; AST, 103 U/L; alkaline phosphatase, 148 U/L; albumin, 5.5 g/dL; and total protein, 7.9 g/dL. Which of the following substances is he most likely to be using?

Accepted Answer

Anabolic steroid

Answer

Acetaminophen

Answer

Chlorpromazine

Answer

Ethyl alcohol

Question 3

Which of the following is NOT a treatment for hepatic encephalopathy?

Accepted Answer

High protein diet

Answer

Lactulose

Answer

Oral neomycin

Answer

Enema

Question 4

Adequacy of D-penicillamine treatment in Wilson's disease is monitored by measuring which of the following?

Accepted Answer

24-hour urinary copper

Answer

Serum ceruloplasmin

Answer

Disappearance of Kayser-Fleischer rings

Answer

Serum copper level in the fasting state

Question 5

Toxic megacolon is seen in:

Accepted Answer

Ulcerative colitis

Answer

Carcinoma of the colon

Answer

Gastrocolic fistula

Answer

Amoebic colitis

Question 6

A 40-year-old lady presents with an Alkaline Phosphatase (ALP) of 550 U/L, SGOT of 75 U/L, total serum bilirubin of 6.5 mg/dL, and conjugated serum bilirubin of 4.3 mg/dL. What is the most likely diagnosis?

Accepted Answer

Obstructive jaundice

Answer

Dubin-Johnson syndrome

Answer

Viral hepatitis

Answer

Cholelithiasis

Question 7

What is the recommended screening method for hepatocellular carcinoma (HCC) in patients with chronic liver disease?

Accepted Answer

Serial Ultrasound (USG) and Alpha-fetoprotein (AFP)

Answer

Serial Liver Function Tests (LFT) and AFP

Answer

Serial LFT and CT scan

Answer

Serial USG and serial LFT

Question 8

The triad originally described for Zollinger-Ellison syndrome is characterized by which of the following?

Accepted Answer

Peptic ulceration, gastric hypersecretion, non-beta cell tumor

Answer

Peptic ulceration, gastric hypersecretion, beta cell tumor

Answer

Peptic ulceration, achlorhydria, non-beta cell tumor

Answer

None of the above

Question 9

Very high serum transaminases (ALT/AST > 1000 IU/L) are seen in the following conditions except?

Accepted Answer

Alcoholic liver disease

Answer

Viral hepatitis

Answer

Ischemic liver injury

Answer

Toxin-induced liver injury

Question 10

Hepatorenal syndrome is characterized by all of the following except?

Accepted Answer

Presence of a precipitating cause

Answer

Serum creatinine more than 1.5 mg/dL

Answer

An intrinsically normal kidney

Answer

Low or absent proteinuria

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?